HIV & AIDS

Antiretroviral HIV medication attenuates liver fibrosis

Scientists from Valencia University (UV) have discovered that Rilpivirine, an antiretroviral drug used for treating HIV, has beneficial effects on chronic liver diseases. The finding opens a path to identify new therapies ...

HIV & AIDS

AIDS deaths down a third since 2010: UN

HIV-related deaths last year fell to around 770,000—some 33 percent lower than in 2010—the United Nations said Tuesday, but warned that global efforts to eradicate the disease were stalling as funding dries up.

HIV & AIDS

Naltrexone implant helps HIV patients prevent opioid relapse

(HealthDay)—Slow-release implantable naltrexone is associated with better outcomes than the oral drug for HIV-positive patients with an opioid addiction, according to a study published in the April issue of The Lancet HIV.

HIV & AIDS

HIV latency differs across tissues in the body

Mechanisms that govern HIV transcription and latency differ in the gut and blood, according to a study published November 15 in the open-access journal PLOS Pathogens by Steven Yukl of San Francisco Veterans Affairs Medical ...

HIV & AIDS

New drug capsule may allow weekly HIV treatment

Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

page 6 from 24